glutamic acid has been researched along with Atherosclerotic Parkinsonism in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.13) | 18.7374 |
| 1990's | 9 (28.13) | 18.2507 |
| 2000's | 10 (31.25) | 29.6817 |
| 2010's | 9 (28.13) | 24.3611 |
| 2020's | 3 (9.38) | 2.80 |
| Authors | Studies |
|---|---|
| Chuang, AY; Chuang, HH; Huang, CS; Lai, YC; Wang, GH; Yang, YC; Yeh, JY | 1 |
| Barsotti, N; Calabrese, V; Calabresi, P; Campanelli, F; Cardinale, A; Ghiglieri, V; Maddaloni, G; Marino, G; Natale, G; Pasqualetti, M; Picconi, B; Usiello, A | 1 |
| Ağar, A; Akçay, G; Aydın Aslan, M; Bülbül, M; Derin, N; Özkan, A; Parlak, H; Sinen, O | 1 |
| An, W; Bai, XX; Bao, LH; Gu, L; Wang, XM; Xi, SS; Yang, HM; Zhang, H | 1 |
| Fang, F; Fang, K; Hou, Z; Lei, H; Lin, X; Liu, M; Liu, S; Meng, H; Sun, B; Zhang, Z | 1 |
| Arnold, JC; Bondada, V; Chotibut, T; Davis, RW; Frenchek, Z; Geddes, JW; Gurwara, S; Salvatore, MF | 1 |
| Chae, Y; Choo, HJ; Doo, AR; Kim, SN; Lee, B; Lee, H; Park, HJ; Park, JJ; Park, JY; Shim, I | 1 |
| Ansah, TA; Ferguson, MC; Nayyar, T | 1 |
| Shimohama, S | 1 |
| Abarca, J; Bustos, G; Bustos, V; Campusano, J; Moya, C; Noriega, V; Riquelme, E | 1 |
| Acher, F; Barabino, E; Beurrier, C; Cuomo, D; Goudet, C; Gubellini, P; Kerkerian-Le Goff, L; Madeo, G; Martella, G; Melon, C; Oueslati, N; Pin, JP; Pisani, A; Platania, P; Selvam, C; Vita, D | 1 |
| Raju, DV; Smith, Y; Villalba, RM | 1 |
| Kuruvilla, KP; Malat, A; Nandhu, MS; Paul, J; Paulose, CS; Romeo, C | 1 |
| Bishop, C; Button, T; Dupre, KB; Eskow Jaunarajs, KL; Ostock, CY; Savage, LM; Wolf, W | 1 |
| Brotchie, JM; Huot, P | 1 |
| Hall, SD; Magill, PJ; Stanford, IM; Woodhall, GL; Yamawaki, N | 1 |
| Freeman, P; Krentz, L; Meshul, CK; Moore, C; Robinson, S; Touchon, JC | 1 |
| Fukuda, R; Fukui, T; Iwanami, A; Kasai, K; Kato, N; Kato, T; Yamasue, H | 1 |
| Hu, XW; Li, BM; Li, FQ; Liu, HH; You, BM; Zhao, XD; Zhou, XP | 1 |
| Brotchie, JM; Crossman, AR; Maneuf, YP; Mitchell, IJ; Woodruff, GN | 1 |
| Cooper, AJ; Laidlaw, SM; Lawson, S; Mitchell, IJ; Moser, B; Walkinshaw, G; Waters, CM | 1 |
| Greenberg, DA | 1 |
| Di Chiara, G; Morelli, M | 1 |
| Greenamyre, JT | 1 |
| Gerlach, M; Gsell, W; Jellinger, K; Kornhuber, J; Krieger, V; Pantucek, F; Riederer, P; Vock, R | 1 |
| Kaur, S; Starr, BS; Starr, MS | 1 |
| Bezard, E; Bioulac, B; Boraud, T; Gross, CE | 1 |
| Andbjer, B; Fuxe, K; Kehr, J; Strömberg, I | 1 |
| Kryzhanovskii, GN; Kucheryanu, VG | 1 |
| Kamel, D; Kay, TS; Krentz, L; Meshul, CK; Moore, C | 1 |
| Beal, MF | 1 |
| Chang, LJ; Hornykiewicz, O; Kish, SJ; Mirchandani, L; Shannak, K | 1 |
5 review(s) available for glutamic acid and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Amyloid beta-Peptides; Animals; Drug Synergism; Galantamine; Glutamic Acid; Motor Neurons; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Oxidopamine; Parkinson Disease, Secondary; Phosphatidylinositol 3-Kinases; Rats; Receptors, Nicotinic; Rotenone; Signal Transduction; Spinal Cord | 2009 |
Glutamate and Parkinson's disease.
Topics: Animals; Brain; Glutamates; Glutamic Acid; Humans; MPTP Poisoning; Parkinson Disease; Parkinson Disease, Secondary; Synaptic Transmission | 1994 |
Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Basal Ganglia; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dopamine Agents; Drug Evaluation, Preclinical; Drug Synergism; Drug Tolerance; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Haplorhini; Humans; Mice; MPTP Poisoning; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Quinoxalines; Rats; Receptors, Dopamine; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 1993 |
Stimulation of basal and L-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Excitatory Amino Acid Antagonists; Glutamic Acid; Levodopa; Motor Activity; Parkinson Disease, Secondary; Rats; Stimulation, Chemical | 1997 |
Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
Topics: Aging; Alzheimer Disease; Animals; Brain Diseases; Cell Death; Energy Metabolism; Glutamates; Glutamic Acid; Humans; Huntington Disease; Ion Channel Gating; Mitochondria; Models, Biological; MPTP Poisoning; Nerve Degeneration; Neurons; Neurotoxins; Oxidative Phosphorylation; Parkinson Disease; Parkinson Disease, Secondary; Primates; Rats; Receptors, N-Methyl-D-Aspartate | 1992 |
27 other study(ies) available for glutamic acid and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Conveyance of cortical pacing for parkinsonian tremor-like hyperkinetic behavior by subthalamic dysrhythmia.
Topics: 4-Aminopyridine; 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Female; Globus Pallidus; Glutamic Acid; Humans; Hyperkinesis; Male; Membrane Potentials; Mice, Inbred C57BL; Motor Cortex; Muscle, Skeletal; Optogenetics; Parkinson Disease, Secondary; Rats; Rats, Wistar; Subthalamic Nucleus; Synapses; Synaptic Transmission; Tremor | 2021 |
Serotonin drives striatal synaptic plasticity in a sex-related manner.
Topics: Animals; Animals, Genetically Modified; Electrophysiological Phenomena; Female; Glutamic Acid; Long-Term Potentiation; Male; Mice; Neostriatum; Nerve Fibers; Neuronal Plasticity; Parkinson Disease, Secondary; Serotonin; Sex Characteristics; Synapses; Synaptic Transmission; Tryptophan Hydroxylase | 2021 |
Neuropeptide-S affects cognitive impairment and depression-like behavior on MPTP induced experimental mouse model of Parkinson’s disease
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cognition; Depression; Disease Models, Animal; Dopamine; Glutamic Acid; Glutamine; Mice; Mice, Inbred C57BL; Neuropeptides; Neuroprotective Agents; Parkinson Disease, Secondary | 2021 |
Metabotropic glutamate receptor 5 mediates the suppressive effect of 6-OHDA-induced model of Parkinson's disease on liver cancer.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Glutamic Acid; Liver; Liver Neoplasms; Male; MAP Kinase Signaling System; Mice; Oxidopamine; Parkinson Disease, Secondary; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5 | 2017 |
Parkinson's disease: in vivo metabolic changes in the frontal and parietal cortices in 6-OHDA treated rats during different periods.
Topics: Animals; Aspartic Acid; Choline; Corpus Striatum; Creatine; Disease Models, Animal; Frontal Lobe; Functional Laterality; Functional Neuroimaging; Glutamates; Glutamic Acid; Glutamine; Magnetic Resonance Spectroscopy; Male; Motor Activity; Oxidopamine; Parietal Lobe; Parkinson Disease, Secondary; Rats; Substantia Nigra; Time Factors | 2014 |
Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model.
Topics: Animals; Ceftriaxone; Corpus Striatum; Glutamic Acid; Male; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2014 |
Combined treatment with acupuncture reduces effective dose and alleviates adverse effect of L-dopa by normalizing Parkinson's disease-induced neurochemical imbalance.
Topics: Acupuncture Therapy; Animals; Antiparkinson Agents; Brain Chemistry; Combined Modality Therapy; gamma-Aminobutyric Acid; Glutamic Acid; Levodopa; Male; Mice; Mice, Inbred C57BL; Movement; Oxidopamine; Parkinson Disease, Secondary; Proto-Oncogene Proteins c-fos; Substantia Nigra | 2014 |
Reverse microdialysis of a 5-HT2A receptor antagonist alters extracellular glutamate levels in the striatum of the MPTP mouse model of Parkinson's disease.
Topics: Animals; Extracellular Space; Fluorobenzenes; Glutamic Acid; Male; Mice; Mice, Inbred C57BL; Microdialysis; MPTP Poisoning; Neostriatum; Parkinson Disease, Secondary; Piperidines; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Synaptosomes | 2014 |
NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
Topics: Analysis of Variance; Animals; Aspartic Acid; Brain-Derived Neurotrophic Factor; Cell Count; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; Functional Laterality; Glutamic Acid; Male; Microdialysis; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase; Up-Regulation | 2009 |
Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment.
Topics: Aminobutyrates; Animals; Antiparkinson Agents; Dose-Response Relationship, Drug; Electrophysiology; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; GABA Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Male; Movement; Neostriatum; Oxidopamine; Parkinson Disease, Secondary; Patch-Clamp Techniques; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Sympatholytics; Synaptic Transmission; Tetrodotoxin | 2009 |
Striatal spine plasticity in Parkinson's disease: pathological or not?
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cerebral Cortex; Corpus Striatum; Dendritic Spines; Diagnosis, Computer-Assisted; Glutamic Acid; Humans; Neural Pathways; Neuronal Plasticity; Neurons; Parkinson Disease; Parkinson Disease, Secondary; Synaptic Transmission | 2009 |
Enhanced glutamate, IP3 and cAMP activity in the cerebral cortex of unilateral 6-hydroxydopamine induced Parkinson's rats: effect of 5-HT, GABA and bone marrow cell supplementation.
Topics: Animals; Behavior, Animal; Bone Marrow Cells; Bone Marrow Transplantation; Cerebral Cortex; Cyclic AMP; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamic Acid; Inositol Phosphates; Male; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Serotonin; Substantia Nigra; Transplantation, Homologous | 2011 |
Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antiparkinson Agents; Benserazide; Benzazepines; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine Agonists; Dyskinesia, Drug-Induced; Glutamic Acid; Levodopa; Male; Microdialysis; Neurons; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin Receptor Agonists | 2011 |
5-HT(1A) receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease: bridging the gap between serotonergic and glutamatergic mechanisms.
Topics: Animals; Corpus Striatum; Dyskinesia, Drug-Induced; Glutamic Acid; Male; Parkinson Disease, Secondary; Receptor, Serotonin, 5-HT1A | 2011 |
Frequency selectivity and dopamine-dependence of plasticity at glutamatergic synapses in the subthalamic nucleus.
Topics: Animals; Dopamine; Electric Stimulation; Excitatory Postsynaptic Potentials; Glutamic Acid; Male; Neuronal Plasticity; Neurons; Organ Culture Techniques; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Subthalamic Nucleus; Synapses; Synaptic Transmission | 2012 |
Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acute Disease; Animals; Chronic Disease; Corpus Striatum; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Glutamic Acid; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Microdialysis; Microscopy, Immunoelectron; Parkinson Disease, Secondary; Presynaptic Terminals; Protein Subunits; Receptors, Glutamate; Synapses; Tyrosine 3-Monooxygenase | 2003 |
Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aspartic Acid; Basal Ganglia Diseases; Choline; Chronic Disease; Creatine; Dominance, Cerebral; Energy Metabolism; Female; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neurologic Examination; Parkinson Disease, Secondary; Phosphocreatine; Putamen; Reference Values; Schizophrenia; Schizophrenic Psychology | 2003 |
[Changes of amino acids neurotransmitters in striatum of hemi-parkinsonian rhesus monkey after high frequency stimulation of subthalamic nucleus].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acids; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Deep Brain Stimulation; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamic Acid; Macaca mulatta; Microdialysis; Neurotoxins; Neurotransmitter Agents; Parkinson Disease, Secondary; Subthalamic Nucleus; Taurine | 2007 |
Functional implications of kappa opioid receptor-mediated modulation of glutamate transmission in the output regions of the basal ganglia in rodent and primate models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Arrhythmia Agents; Basal Ganglia; Benzofurans; Callithrix; Female; Glutamic Acid; In Vitro Techniques; Male; Motor Activity; Naltrexone; Parkinson Disease, Secondary; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reserpine; Synaptic Transmission | 1995 |
Glutamate-induced apoptosis results in a loss of striatal neurons in the parkinsonian rat.
Topics: Animals; Apoptosis; Excitatory Amino Acid Antagonists; Glutamic Acid; Neostriatum; Neural Pathways; Neurons; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Reserpine | 1994 |
Dopamine-acetylcholine-glutamate interactions in the striatum. A working hypothesis.
Topics: Acetylcholine; Animals; Corpus Striatum; Dopamine; Glutamates; Glutamic Acid; Humans; Neurons; Parkinson Disease; Parkinson Disease, Secondary; Rats; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 1993 |
A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Basal Ganglia; Biomarkers; Cerebral Cortex; Dopamine; Female; gamma-Aminobutyric Acid; Glutamic Acid; Homovanillic Acid; Humans; Kinetics; Male; Middle Aged; Neurons; Parkinson Disease, Secondary; Thalamus | 1996 |
Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adaptation, Physiological; Animals; Dopamine Agents; Electrophysiology; Globus Pallidus; Glutamic Acid; Macaca fascicularis; Parkinson Disease, Secondary; Thalamic Nuclei | 1999 |
Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
Topics: Animals; Apomorphine; Benzazepines; Brain Tissue Transplantation; Corpus Striatum; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Fetal Tissue Transplantation; Glutamic Acid; Membrane Potentials; Mesencephalon; Microdialysis; Microelectrodes; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Tyrosine 3-Monooxygenase | 2000 |
Effect of glutamate and antagonists of N-methyl-D-aspartate receptors on experimental parkinsonian syndrome in rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Excitatory Amino Acid Antagonists; Glutamic Acid; Ketamine; Male; Memantine; Parkinson Disease, Secondary; Rats; Receptors, N-Methyl-D-Aspartate | 2000 |
Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats.
Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Corpus Striatum; Drug Administration Schedule; Drug Antagonism; Extracellular Space; Glutamic Acid; Immunohistochemistry; Male; Microdialysis; Microscopy, Electron; Motor Activity; Nicotine; Nicotinic Agonists; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Synapses | 2002 |
Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers.
Topics: Aged; Aspartic Acid; Basal Ganglia Diseases; Brain; Bulbar Palsy, Progressive; Choline O-Acetyltransferase; Dementia; Dopamine; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Neurons; Neurotransmitter Agents; Norepinephrine; Parkinson Disease, Secondary; Serotonin | 1985 |